Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Adagio Medical Holdings (ADGM) EPS (Basic) (2023 - 2026)

Adagio Medical Holdings has reported EPS (Basic) over the past 4 years, most recently at -$0.31 for Q1 2026.

  • Quarterly EPS (Basic) rose 38.0% to -$0.31 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $23.34 through Mar 2026, up 244.16% year-over-year, with the annual reading at -$1.51 for FY2025, 55.33% up from the prior year.
  • EPS (Basic) was -$0.31 for Q1 2026 at Adagio Medical Holdings, down from $24.57 in the prior quarter.
  • Over five years, EPS (Basic) peaked at $24.57 in Q4 2025 and troughed at -$14.15 in Q3 2023.
  • The 4-year median for EPS (Basic) is -$4.0 (2024), against an average of -$2.86.
  • Year-over-year, EPS (Basic) surged 96.46% in 2025 and then surged 38.0% in 2026.
  • A 4-year view of EPS (Basic) shows it stood at -$11.33 in 2023, then grew by 26.39% to -$8.34 in 2024, then surged by 394.6% to $24.57 in 2025, then crashed by 101.26% to -$0.31 in 2026.
  • Per Business Quant, the three most recent readings for ADGM's EPS (Basic) are -$0.31 (Q1 2026), $24.57 (Q4 2025), and -$0.66 (Q3 2025).